Special Anniversary Offer: Vanishing Tomorrow - Your Chance to Save 80%
Here is the latest financial fact sheet of ASPIRA PATHLAB & DIAGNOSTICS . For more details, see the ASPIRA PATHLAB & DIAGNOSTICS quarterly results and ASPIRA PATHLAB & DIAGNOSTICS share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 1.2 |
No. of shares | m | 10.29 |
1 Week | % | -3.0 |
1 Month | % | -5.6 |
1 Year | % | -6.9 |
52 week H/L | Rs | 49.5/22.8 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
ASPIRA PATHLAB & DIAGNOSTICS EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 27 | 38 | 37 | 124 | 75 | |
Low | Rs | 18 | 29 | 20 | 30 | 26 | |
Sales per share (Unadj.) | Rs | 9.3 | 9.1 | 14.8 | 19.0 | 14.0 | |
Earnings per share (Unadj.) | Rs | -6.3 | -4.6 | 1.3 | 4.3 | -0.1 | |
Diluted earnings per share | Rs | -5.0 | -4.1 | 1.3 | 4.3 | -0.1 | |
Cash flow per share (Unadj.) | Rs | -4.8 | -2.8 | 2.7 | 5.9 | 1.5 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 6.3 | 4.1 | 8.1 | 12.4 | 12.4 | |
Adj. book value per share | Rs | 5.0 | 3.7 | 8.1 | 12.4 | 12.4 | |
Shares outstanding (eoy) | m | 8.19 | 9.29 | 10.29 | 10.29 | 10.29 | |
Price / Sales ratio | x | 2.4 | 3.7 | 1.9 | 4.1 | 3.6 | |
Avg P/E ratio | x | -3.6 | -7.3 | 21.1 | 17.8 | -583.7 | |
P/CF ratio (eoy) | x | -4.7 | -12.1 | 10.3 | 13.0 | 34.6 | |
Price / Book Value ratio | x | 3.6 | 8.2 | 3.5 | 6.2 | 4.1 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 185 | 311 | 291 | 793 | 518 | |
Total wages/salary | Rs m | 45 | 49 | 40 | 50 | 56 |
ASPIRA PATHLAB & DIAGNOSTICS INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 76 | 84 | 152 | 195 | 145 | |
Other income | Rs m | 3 | 3 | 2 | 2 | 3 | |
Total revenues | Rs m | 79 | 87 | 154 | 197 | 148 | |
Gross profit | Rs m | -32 | -18 | 35 | 63 | 16 | |
Depreciation | Rs m | 12 | 17 | 14 | 16 | 16 | |
Interest | Rs m | 10 | 10 | 9 | 4 | 4 | |
Profit before tax | Rs m | -52 | -42 | 14 | 45 | -1 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 0 | 0 | 0 | 0 | 0 | |
Profit after tax | Rs m | -52 | -42 | 14 | 45 | -1 | |
Gross profit margin | % | -42.5 | -21.7 | 23.1 | 32.3 | 11.0 | |
Effective tax rate | % | 0 | -0.7 | 0 | 0 | 0 | |
Net profit margin | % | -67.9 | -50.4 | 9.1 | 22.8 | -0.6 |
ASPIRA PATHLAB & DIAGNOSTICS BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 23 | 33 | 39 | 71 | 59 | |
Current liabilities | Rs m | 42 | 51 | 20 | 18 | 16 | |
Net working cap to sales | % | -25.0 | -21.8 | 12.3 | 27.4 | 29.5 | |
Current ratio | x | 0.5 | 0.6 | 1.9 | 4.0 | 3.7 | |
Inventory Days | Days | 172 | 102 | 3 | 26 | 88 | |
Debtors Days | Days | 38,049,819 | 262 | 409 | 839 | 590 | |
Net fixed assets | Rs m | 125 | 110 | 79 | 110 | 115 | |
Share capital | Rs m | 82 | 93 | 103 | 103 | 103 | |
"Free" reserves | Rs m | -30 | -55 | -20 | 25 | 25 | |
Net worth | Rs m | 52 | 38 | 83 | 128 | 128 | |
Long term debt | Rs m | 48 | 46 | 8 | 9 | 10 | |
Total assets | Rs m | 148 | 143 | 118 | 181 | 173 | |
Interest coverage | x | -4.4 | -3.2 | 2.5 | 13.0 | 0.8 | |
Debt to equity ratio | x | 0.9 | 1.2 | 0.1 | 0.1 | 0.1 | |
Sales to assets ratio | x | 0.5 | 0.6 | 1.3 | 1.1 | 0.8 | |
Return on assets | % | -28.5 | -22.5 | 19.3 | 26.6 | 1.9 | |
Return on equity | % | -99.8 | -111.6 | 16.6 | 34.9 | -0.7 | |
Return on capital | % | -42.3 | -38.3 | 25.0 | 35.4 | 2.4 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx outflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Net fx | Rs m | 0 | 0 | 0 | 0 | 0 |
ASPIRA PATHLAB & DIAGNOSTICS CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | -34 | -19 | 57 | 20 | -0 | |
From Investments | Rs m | -20 | 2 | -1 | -5 | 2 | |
From Financial Activity | Rs m | 34 | 13 | -22 | -14 | -9 | |
Net Cashflow | Rs m | -20 | -4 | 34 | 2 | -8 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Haseeb Drabu | COMP SEC: Krupali Shah | YEAR OF INC: 1973 | BSE CODE: 540788 | FV (Rs): 10 | DIV YIELD (%): - |
More Hospital & Healthcare Services Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare ASPIRA PATHLAB & DIAGNOSTICS With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.